319 related articles for article (PubMed ID: 11972582)
1. Open label trial of coenzyme Q10 as a migraine preventive.
Rozen TD; Oshinsky ML; Gebeline CA; Bradley KC; Young WB; Shechter AL; Silberstein SD
Cephalalgia; 2002 Mar; 22(2):137-41. PubMed ID: 11972582
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial.
Shoeibi A; Olfati N; Soltani Sabi M; Salehi M; Mali S; Akbari Oryani M
Acta Neurol Belg; 2017 Mar; 117(1):103-109. PubMed ID: 27670440
[TBL] [Abstract][Full Text] [Related]
3. The effects of concurrent Coenzyme Q10, L-carnitine supplementation in migraine prophylaxis: A randomized, placebo-controlled, double-blind trial.
Hajihashemi P; Askari G; Khorvash F; Reza Maracy M; Nourian M
Cephalalgia; 2019 Apr; 39(5):648-654. PubMed ID: 30612463
[TBL] [Abstract][Full Text] [Related]
4. Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis.
Bianchi A; Salomone S; Caraci F; Pizza V; Bernardini R; D'Amato CC
Vitam Horm; 2004; 69():297-312. PubMed ID: 15196887
[TBL] [Abstract][Full Text] [Related]
5. A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.
Guilbot A; Bangratz M; Ait Abdellah S; Lucas C
BMC Complement Altern Med; 2017 Aug; 17(1):433. PubMed ID: 28854909
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine.
Slater SK; Nelson TD; Kabbouche MA; LeCates SL; Horn P; Segers A; Manning P; Powers SW; Hershey AD
Cephalalgia; 2011 Jun; 31(8):897-905. PubMed ID: 21586650
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial.
Sándor PS; Di Clemente L; Coppola G; Saenger U; Fumal A; Magis D; Seidel L; Agosti RM; Schoenen J
Neurology; 2005 Feb; 64(4):713-5. PubMed ID: 15728298
[TBL] [Abstract][Full Text] [Related]
8. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine.
Hershey AD; Powers SW; Vockell AL; Lecates SL; Ellinor PL; Segers A; Burdine D; Manning P; Kabbouche MA
Headache; 2007 Jan; 47(1):73-80. PubMed ID: 17355497
[TBL] [Abstract][Full Text] [Related]
9. Effect of coenzyme Q10 supplementation on clinical features of migraine: a systematic review and dose-response meta-analysis of randomized controlled trials.
Parohan M; Sarraf P; Javanbakht MH; Ranji-Burachaloo S; Djalali M
Nutr Neurosci; 2020 Nov; 23(11):868-875. PubMed ID: 30727862
[No Abstract] [Full Text] [Related]
10. Oral coenzyme Q10 supplementation in patients with migraine: Effects on clinical features and inflammatory markers.
Dahri M; Tarighat-Esfanjani A; Asghari-Jafarabadi M; Hashemilar M
Nutr Neurosci; 2019 Sep; 22(9):607-615. PubMed ID: 29298622
[No Abstract] [Full Text] [Related]
11. The synergistic effects of nano-curcumin and coenzyme Q10 supplementation in migraine prophylaxis: a randomized, placebo-controlled, double-blind trial.
Parohan M; Sarraf P; Javanbakht MH; Foroushani AR; Ranji-Burachaloo S; Djalali M
Nutr Neurosci; 2021 Apr; 24(4):317-326. PubMed ID: 31241007
[No Abstract] [Full Text] [Related]
12. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial.
Gaul C; Diener HC; Danesch U;
J Headache Pain; 2015; 16():516. PubMed ID: 25916335
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
[TBL] [Abstract][Full Text] [Related]
15. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
[TBL] [Abstract][Full Text] [Related]
16. Coenzyme Q10.
Med Lett Drugs Ther; 2006 Feb; 48(1229):19-20. PubMed ID: 16498307
[No Abstract] [Full Text] [Related]
17. Clinical aspects of coenzyme Q10: an update.
Littarru GP; Tiano L
Curr Opin Clin Nutr Metab Care; 2005 Nov; 8(6):641-6. PubMed ID: 16205466
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
[TBL] [Abstract][Full Text] [Related]
19. Ginkgolide B complex efficacy for brief prophylaxis of migraine in school-aged children: an open-label study.
Esposito M; Carotenuto M
Neurol Sci; 2011 Feb; 32(1):79-81. PubMed ID: 20872034
[TBL] [Abstract][Full Text] [Related]
20. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease.
Shults CW; Flint Beal M; Song D; Fontaine D
Exp Neurol; 2004 Aug; 188(2):491-4. PubMed ID: 15246848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
